Your shopping cart is currently empty

PQR620 is a novel potent and selective, brain penetrant inhibitor of mTORC1/2.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $41 | In Stock | In Stock | |
| 5 mg | $107 | In Stock | In Stock | |
| 10 mg | $155 | In Stock | In Stock | |
| 25 mg | $261 | In Stock | In Stock | |
| 50 mg | $372 | In Stock | In Stock | |
| 100 mg | $498 | In Stock | In Stock | |
| 1 mL x 10 mM (in DMSO) | $103 | In Stock | In Stock |
| Description | PQR620 is a novel potent and selective, brain penetrant inhibitor of mTORC1/2. |
| In vitro | PQR620 is a potent and selective mTOR inhibitor with >1000-fold selectivity over PI3Kα in enzymatic binding assays. In A2058 melanoma cells, it inhibits protein kinase B (pSer473) and ribosomal protein S6 (pSer235/236) phosphorylation with IC50 values of 0.2 μM and 0.1 μM, respectively. PQR620 exhibits excellent selectivity across a broad range of kinases, receptor enzymes, and ion channels, and effectively prevents cancer cell growth in the NTRC 44 cancer cell line panel, achieving a 10log(IC50) of 2.86 (nM). |
| In vivo | PQR620 exhibits favorable physico-chemical properties, leading to good oral bioavailability and excellent brain penetration. |
| Molecular Weight | 445.47 |
| Formula | C21H25F2N7O2 |
| Cas No. | 1927857-56-4 |
| Smiles | [H][C@]12CC[C@]([H])(COC1)N2c1nc(nc(n1)-c1cnc(N)cc1C(F)F)N1[C@@]2([H])CC[C@]1([H])COC2 |
| Relative Density. | 1.403 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| Solubility Information | DMSO: 6.4 mg/mL (14.37 mM), Sonication is recommended. | ||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 1 mg/mL (2.24 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
| |||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.